Artelo Biosciences is a clinical stage company using cutting-edge science to improve patient care.
We were founded in 2017 on the promise of therapeutic development based on lipid-signaling modification, including targeting the receptors of the endocannabinoid system.
Our mission is to alter the course of treatment for those with a diagnosis of cancer and other serious conditions.